Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma

Cancer Letters
Tang LiuZhenfeng Duan

Abstract

Sarcomas include some of the most aggressive tumors and typically respond poorly to chemotherapy. In recent years, specific gene fusion/mutations and gene over-expression/activation have been shown to drive sarcoma pathogenesis and development. These emerging genomic alterations may provide targets for novel therapeutic strategies and have the potential to transform sarcoma patient care. The RNA-guided nuclease CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein-9 nuclease) is a convenient and versatile platform for site-specific genome editing and epigenome targeted modulation. Given that sarcoma is believed to develop as a result of genetic alterations in mesenchymal progenitor/stem cells, CRISPR-Cas9 genome editing technologies hold extensive application potentials in sarcoma models and therapies. We review the development and mechanisms of the CRISPR-Cas9 system in genome editing and introduce its application in sarcoma research and potential therapy in clinic. Additionally, we propose future directions and discuss the challenges faced with these applications, providing concise and enlightening information for readers interested in this area.

References

Sep 21, 2002·Molecular and Cellular Biology·Irina LagutinaGerard C Grosveld
Dec 11, 2003·Microbiology and Molecular Biology Reviews : MMBR·Neema AgrawalSunil K Mukherjee
Dec 3, 2004·Genes & Development·Jan-Hermen DannenbergHein te Riele
Oct 27, 2006·Pediatric Blood & Cancer·Peter J HoughtonMalcolm A Smith
Oct 31, 2006·The Journal of Pathology·L StrizziD S Salomon
Apr 4, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·E de Alava
Apr 10, 2007·Cancer Cell·Malay HaldarMario R Capecchi
Jun 9, 2007·Critical Reviews in Oncology/hematology·Katharina TschoepRolf-Dieter Issels
Aug 11, 2007·The Journal of Pathology·N RiggiI Stamenkovic
Mar 29, 2008·Methods in Molecular Biology·Doreen E Wesche-SoldatoAlfred Ayala
Oct 22, 2009·Cancer Research·Deyin XingSandra Orsulic
Jan 7, 2011·PloS One·Daniel A RauchKatherine N Weilbaecher
Jul 15, 2011·Nature Reviews. Cancer·Barry S TaylorMarc Ladanyi
Feb 2, 2012·The Journal of Clinical Investigation·Elizabeth CharytonowiczIgor Matushansky
Apr 14, 2012·Advances in Anatomic Pathology·Elizabeth G DemiccoAlexander J Lazar
Jul 14, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhenfeng DuanFrancis J Hornicek
Jul 25, 2012·Nature Reviews. Cancer·Oliver Rath, Frank Kozielski
Oct 6, 2012·Clinical Sarcoma Research·Alvin Jm NgCarl R Walkley
Jan 5, 2013·Science·Le CongFeng Zhang
Jun 26, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nancy Maizels
Oct 1, 2013·Nature Methods·Prashant MaliGeorge M Church
Dec 4, 2013·Genes & Development·Abba MalinaJerry Pelletier
Dec 18, 2013·Science·Ophir ShalemFeng Zhang
Mar 22, 2014·Human Molecular Genetics·Feng ZhangXiong Guo
Apr 25, 2014·Nature Communications·Peter S Choi, Matthew Meyerson
May 17, 2014·Science·Rodolphe Barrangou
Jun 16, 2014·Nature Chemical Biology·Corynn KasapTarun M Kapoor

❮ Previous
Next ❯

Citations

Oct 25, 2016·Biochimica Et Biophysica Acta·Lang Yi, Jinming Li
Sep 28, 2016·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Ylermi Soini
Apr 27, 2017·Current Opinion in Oncology·Rainer Hamacher, Sebastian Bauer
Feb 22, 2018·International Journal of Molecular Sciences·Gianluca ColellaFilomena de Nigris
Jun 15, 2019·Journal of Drug Targeting·Stefanie A PenaAdrien A Eshraghi
Mar 3, 2019·Antibiotics·Alexandre Loureiro, Gabriela Jorge da Silva
Nov 1, 2018·Advanced Biosystems·Rachel L MintzKam W Leong
Jun 10, 2021·Biologics : Targets & Therapy·Markeshaw Tiruneh G/MedhinTadesse Asmamaw Dejenie

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR Screens in Drug Resistance (ASM)

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.